Exchange & Returns Information
Review Details
(24)
| Drug Type | Original |
|---|---|
| Active Ingredient | TIRZEPATIDE |
| Strength | 12.5MG |
| Manufacturer | ELI LILLY AND COMPANY |
| Pack Size | Price Per Unit | Unit Price | QTY | CART | Best Coupon Price MAX DISCOUNT |
|---|---|---|---|---|---|
| 1 BOX - 1 PEN | $ 375.00 | $ 375.00 |
$ 315.00
Apply MOUN26 (-16%)
You save $ 60.00
|
||
| 2 BOXES - 2 PENS | $ 362.50 |
3% $ 750.00
$ 725.00
|
$ 609.00
Apply MOUN26 (-16%)
You save $ 116.00
|
||
| ★ Best Value 3 BOXES - 3 PENS | $ 345.00 |
8% $ 1,125.00
$ 1,035.00
|
$ 869.40
Apply MOUN26 (-16%)
You save $ 165.60
|
Reference information will be available soon.
Mounjaro 12.5mg is a once-weekly GLP‑1 and GIP dual agonist injection designed for glycemic control in type 2 diabetes. It is not primarily a weight loss drug but has shown consistent weight reduction across doses. This dose level represents an advanced therapeutic stage following titration from lower strengths (2.5mg, 5mg, 7.5mg, 10mg). While approved for diabetes, studies have explored off-label benefits in obesity-related conditions such as obstructive sleep apnea (OSA), prediabetes progression, and metabolic cancer modulation. Mounjaro’s dual incretin action supports enhanced insulin secretion and appetite regulation.
- DIABETES (GLP-1 Receptor Agonists) > Type 2 Diabetes Mellitus Used to improve glycemic control in adults with type 2 diabetes. HbA1c and fasting/postprandial glucose levels are significantly reduced through dual incretin activity. - DIET (Metabolic Weight Control) > Secondary metabolic weight loss Not a primary weight loss agent, but consistent reductions in body weight have been observed in clinical trials as a secondary outcome. - LIFESTYLE-RELATED DISEASES (Obstructive Sleep Apnea – off-label) > Off-label support for OSA with comorbid obesity Tirzepatide-induced weight reduction has been shown to improve OSA severity in some patients. This effect is not a primary indication but supported by Zepbound data. - AntiCancer Drugs (Others – metabolic-linked cancer modulation) > Research-based adjunct for obesity-related cancers Early preclinical studies indicate tirzepatide may influence metabolic pathways involved in cancers such as breast cancer. Still under investigation.
Tirzepatide functions as a dual incretin mimetic, activating GLP‑1 and GIP receptors to enhance insulin secretion, delay gastric emptying, and reduce appetite. These combined effects improve glycemic control while promoting metabolic weight reduction.
➔ Weekly Subcutaneous Injection (Type 2 Diabetes Indication): - Week 1–4: 2.5 mg SC once weekly (initiation only) - Week 5+: 5 mg SC once weekly (first active dose) - Further escalation: - 7.5 mg → 10 mg → 12.5 mg → up to 15 mg weekly (4-week interval titration based on tolerance) ➔ Maintenance Dose: 5–15 mg SC per week ➔ Maximum Dose: 15 mg per week ➔ Administration Notes: - Inject into abdomen, upper arm, or thigh - Same day each week, with or without food - If a dose is missed, inject within 96 hours; skip if longer ➔ Drug Interactions / Adjustments: - Can be used with metformin, SGLT2 inhibitors, sulfonylureas, or basal insulin - Reduce sulfonylurea or insulin dose to prevent hypoglycemia ➔ Special Considerations: - Not for type 1 diabetes or diabetic ketoacidosis - Contraindicated in medullary thyroid carcinoma or MEN2 history - Monitor renal function and diabetic retinopathy in high-risk patients ➔ Off-Label Observations: - May lower risk of diabetes onset in prediabetic patients (up to 94%) - Research ongoing in metabolic modulation of Alzheimer’s and obesity-linked cancers - Indirect benefits observed in OSA patients with obesity
Store unused pens in the refrigerator (2–8°C). Do not freeze. Once opened, store at room temperature (below 30°C) for up to 21 days. Protect from light and moisture. Keep out of reach of children.
Common side effects include nausea, vomiting, constipation, diarrhea, and decreased appetite. Other effects may include fatigue, dizziness, indigestion, and injection site reactions. Serious risks (rare) include pancreatitis, gallbladder issues, acute kidney injury, and hypoglycemia (especially with insulin or sulfonylureas). Persistent or severe side effects require medical attention.
My A1c is the best it's been in a decade. This medication, supplied by a reliable pharmacy, has been key.
I love that the site is clean, fast, and not cluttered with ads. It makes for a very professional and pleasant user experience.
Five months into my Mounjaro journey and feeling great. This pharmacy has been an essential partner.
My 12.5mg Mounjaro pen arrived in Canada without a single issue. This site is consistently reliable.
This month, I had a minor panic because I entered my credit card's CVC code incorrectly and the order wouldn't process. I was worried it would delay my shipment. I contacted their customer support, and the agent was incredibly calming and professional. She helped me cancel the failed order and place a new one correctly in a matter of minutes. This efficient, human-centric support is what makes them a truly exceptional company.
No combo deals available at the moment.
